DrugPatentWatch Database Preview

CLINICAL TRIALS PROFILE FOR IXABEPILONE

« Back to Dashboard

Clinical Trials for Ixabepilone

Trial ID	Title	Status	Sponsor	Phase	Start Date	Summary
NCT00004927	BMS-247550 in Treating Patients With Advanced Solid Tumors That Have Not Responded to Previous Therapy	Completed	Memorial Sloan Kettering Cancer Center	Phase 1	1999-07-01	RATIONALE: Drugs used in chemotherapy use different ways to stop tumor cells from dividing so they stop growing or die. PURPOSE: Phase I trial to study the effectiveness of BMS-247550 in treating patients who have advanced solid tumors that have not responded to previous therapy.
NCT00004927	BMS-247550 in Treating Patients With Advanced Solid Tumors That Have Not Responded to Previous Therapy	Completed	National Cancer Institute (NCI)	Phase 1	1999-07-01	RATIONALE: Drugs used in chemotherapy use different ways to stop tumor cells from dividing so they stop growing or die. PURPOSE: Phase I trial to study the effectiveness of BMS-247550 in treating patients who have advanced solid tumors that have not responded to previous therapy.
NCT00004927	BMS-247550 in Treating Patients With Advanced Solid Tumors That Have Not Responded to Previous Therapy	Completed	Bristol-Myers Squibb	Phase 1	1999-07-01	RATIONALE: Drugs used in chemotherapy use different ways to stop tumor cells from dividing so they stop growing or die. PURPOSE: Phase I trial to study the effectiveness of BMS-247550 in treating patients who have advanced solid tumors that have not responded to previous therapy.
NCT00005807	BMS-247550 in Treating Patients With Advanced Solid Tumors, Breast Cancer or Recurrent Ovarian Cancer	Completed	National Cancer Institute (NCI)	Phase 1	2000-07-01	RATIONALE: Drugs used in chemotherapy use different ways to stop tumor cells from dividing so they stop growing or die. PURPOSE: Phase I trial to study the effectiveness of BMS-247550 in treating patients who have metastatic, recurrent, or locally advanced, ovarian cancer, breast cancer, or metastatic or unresectable solid tumors.

Clinical Trial Conditions for Ixabepilone

Condition Name

Condition Name for Ixabepilone
Intervention	Trials
Breast Cancer	23
Metastatic Breast Cancer	17
Unspecified Adult Solid Tumor, Protocol Specific	9
Stage IV Breast Cancer	7

Export unavailable in trial.
Subscribe for complete access.

Condition MeSH

Condition MeSH for Ixabepilone
Intervention	Trials
Breast Neoplasms	46
Carcinoma	11
Adenocarcinoma	9
Prostatic Neoplasms	8

Export unavailable in trial.
Subscribe for complete access.

Clinical Trial Locations for Ixabepilone

Trials by Country

Trials by Country for Ixabepilone
Location	Trials
United States	599
Italy	24
Japan	18
United Kingdom	15
Argentina	12

Export unavailable in trial.
Subscribe for complete access.

Trials by US State

Trials by US State for Ixabepilone
Location	Trials
California	30
New York	30
Maryland	29
Florida	28
Texas	26

Export unavailable in trial.
Subscribe for complete access.

Clinical Trial Progress for Ixabepilone

Clinical Trial Phase

Clinical Trial Phase for Ixabepilone
Clinical Trial Phase	Trials
Phase 3	7
Phase 2	64
Phase 1/Phase 2	12

Export unavailable in trial.
Subscribe for complete access.

Clinical Trial Status

Clinical Trial Status for Ixabepilone
Clinical Trial Phase	Trials
Completed	69
Terminated	19
Active, not recruiting	12

Export unavailable in trial.
Subscribe for complete access.

Clinical Trial Sponsors for Ixabepilone

Sponsor Name

Sponsor Name for Ixabepilone
Sponsor	Trials
National Cancer Institute (NCI)	52
Bristol-Myers Squibb	28
R-Pharm	18

Export unavailable in trial.
Subscribe for complete access.

Sponsor Type

Sponsor Type for Ixabepilone
Sponsor	Trials
Industry	67
Other	55
NIH	53

Export unavailable in trial.
Subscribe for complete access.